Selling into a wave of new capacity being built by others: management describes its customers' own build-out spending as
The model's full reasoning — Q3 2023 call → NOWe need to determine if management explains current momentum and near-term trajectory chiefly by pointing to a wave of new building/equipping/capacity-creation by other parties, with the company already supplying part of that, and the wave being early. Let's analyze the transcript. The call is about Enovis, a medical technology company. They discuss Recon (reconstructive) and P&R (prevention and recovery). They mention growth, margins, acquisitions, etc. Key points: They talk about elective surgery markets, procedure volumes, pandemic-related patient backlogs. They mention "we believe the elective surgery markets we serve remain healthy with higher than normal procedural demand in 2023 overall, a trend we expect will persist through 2024 and likely 2025 as pandemic-related patient backlogs are gradually worked down." This is about patient demand for procedures, not about building capacity by others. They talk about their own innovation, share gains, etc. They also discuss the Lima acquisition, which is about expanding their own business, not about others building. There is no mention of customers building new facilities, hospitals, clinics, or any capacity creation. The demand is from patients needing procedures, which is consumption of healthcare services, not building new capacity. The company supplies implants and equipment, but the demand is driven by patient volumes, not by others constructing new facilities. The question asks: "does management explain the company's current momentum and near-term trajectory chiefly by pointing to A WAVE OF NEW BUILDING, EQUIPPING, OR CAPACITY-CREATION BEING UNDERTAKEN BY OTHER PARTIES — its customers, its customers' customers, or institutions in its end markets — for which the company already supplies part of what those parties must buy, AND does management convey that this outside build-out is early or intensifying rather than mature, so that the business it will bring the company is mostly still ahead?" In the transcript, management talks about patient backlogs, which is about deferred procedures, not about building new capacity. They don't mention hospitals expanding, new clinics, etc. They talk about their own product launches and share gains. So the answer is NO. We need to be careful: The question is about "building, equipping, or capacity-creation" by others. The transcript does not describe that.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
TEL · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by others, that's early or intensif...YES The transcript shows management framing the company's momentum chiefly through a wave of external capacity creation: EV production growth (40% in 2023, expected continued growth next year, with Asia as driver), renewable energy adoption (wind/solar), and AI/cloud applications. They describe others (OEMs, installers 3rd parties) building new productive capability—new EV platforms, renewable sites, AI clusters—while TE already supplies into it via content outperformance and early ramps. Current business is real (sequential order growth, $1.3B pipeline, $100M+ incremental AI revenue). The wave is early/intensifying 2024–2025 (3–4 year programs, more phases ahead, destocking normalizing). This is presented as the primary secular driver offsetting cyclical weakness, not just consumption or pricing. Other elements (destocking, FX) are secondary. Thus all three conditions are met in substance.
ATI · Q1 2018 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by other parties, like customers, t...YES The transcript shows management attributing HPMC momentum chiefly to the "ongoing production ramp of next-generation jet engines at all of our major engine OEM customers" and the "industry is currently in the early phases of a multi-year production expansion." This describes OEMs creating new productive capacity through rate ramps and build growth for next generation engines. Management confirms current business from this wave with "next-generation product sales reached 48% of total jet engine product sales" and "65% increase in next-generation product sales," plus "seventh consecutive quarter of year-over-year margin expansion.
RDCM · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building, equipping, or capacity-creation by other parties (custo...YES The transcript shows management framing 2024 momentum around operators’ ongoing 5G standalone network build-outs (new productive capacity being created by customers), with RADCOM already supplying assurance software to those projects and the wave described as still early and accelerating. All three conditions are met in Eyal Harari’s prepared remarks and Q&A.